Literature DB >> 12070266

Detection of pyruvate dehydrogenase E1 alpha-subunit deficiencies in females by immunohistochemical demonstration of mosaicism in cultured fibroblasts.

Margarita Y Lib1, Ruth M Brown, Garry K Brown, Michael F Marusich, Roderick A Capaldi.   

Abstract

Deficiency of the E1 alpha-subunit of the pyruvate dehydrogenase (PDH) complex is an X-linked inborn error of metabolism and one of the major causes of lactic acidosis in children. Although most heterozygous females manifest symptoms of the disease, it is often difficult to establish the diagnosis as results based on measurement of total PDH activity, and E1 alpha-immunoreactive protein in patient fibroblasts may be ambiguous because of the variability in the pattern of X chromosome inactivation. We report the development of a set of monoclonal antibodies (MAbs) specific to four subunits of the PDH complex that can be used for detection of PDH E1 alpha deficiency. We also show that anti-E1 alpha and anti-E2 MAbs, when used in immunocytochemical analysis, can detect mosaicism in cell cultures from female patients in which as few as 2-5% of cells express the deficiency. This immunocytochemical approach, which is fast, reliable, and quantitative, will be particularly useful in identifying females with PDH E1 alpha-subunit deficiency as a precursor to mutation analysis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12070266     DOI: 10.1177/002215540205000701

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  6 in total

Review 1.  The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients.

Authors:  Kavi P Patel; Thomas W O'Brien; Sankarasubramon H Subramony; Jonathan Shuster; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2011-10-07       Impact factor: 4.797

2.  Somatic mosaicism for a PDHA1 mutation in a female with pyruvate dehydrogenase deficiency.

Authors:  Cheryl K Ridout; Ruth M Brown; John H Walter; Garry K Brown
Journal:  Hum Genet       Date:  2008-08-17       Impact factor: 4.132

3.  The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients.

Authors:  Kavi P Patel; Thomas W O'Brien; Sankarasubramon H Subramony; Jonathan Shuster; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2012-07       Impact factor: 4.797

4.  Cerebral Developmental Abnormalities in a Mouse with Systemic Pyruvate Dehydrogenase Deficiency.

Authors:  Lioudmila Pliss; Kathryn A Hausknecht; Michal K Stachowiak; Cynthia A Dlugos; Jerry B Richards; Mulchand S Patel
Journal:  PLoS One       Date:  2013-06-26       Impact factor: 3.240

Review 5.  Comparison Between Dichloroacetate and Phenylbutyrate Treatment for Pyruvate Dehydrogenase Deficiency.

Authors:  Patricia Karissa; Timothy Simpson; Simon P Dawson; Teck Yew Low; Sook Hui Tay; Fatimah Diana Amin Nordin; Shamsul Mohd Zain; Pey Yee Lee; Yuh-Fen Pung
Journal:  Br J Biomed Sci       Date:  2022-05-19       Impact factor: 2.432

6.  Differential phenotypic expression of a novel PDHA1 mutation in a female monozygotic twin pair.

Authors:  Alejandro Horga; Catherine E Woodward; Alberto Mills; Isabel Pareés; Iain P Hargreaves; Ruth M Brown; Enrico Bugiardini; Tony Brooks; Andreea Manole; Elena Remzova; Shamima Rahman; Mary M Reilly; Henry Houlden; Mary G Sweeney; Garry K Brown; James M Polke; Federico Gago; Matthew J Parton; Robert D S Pitceathly; Michael G Hanna
Journal:  Hum Genet       Date:  2019-10-31       Impact factor: 4.132

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.